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enable percutaneous transluminal angioplasty (PTA)
when transfemoral access is not feasible.1 Manual
compression at the transbrachial puncture site is labor-
intensive, time-consuming and uncomfortable for the
patient. Local complications may occur.2
Angio-Seale was introduced as a hemostatic
closure device at the femoral puncture site.3,4 This
technique is timesaving and there is no further need
for manual compression. We describe a strategy for the
off-label use of 6F-Angio-Seale deployment of punc-
ture closure of the brachial artery after transbrachial
PTA. A brief retrospective analysis over 1 year was
carried out to evaluate local complications.Patients and MethodsPatients
During a period of 12 months in 2003, 36 patients
(mean age: 63.5 years; range: 43–81 years; m: 27, f: 9)
were evaluated retrospectively. The patients suffered
either from peripheral ischemia of the leg (Fontaine
stage IIb nZ14, stage III nZ10; stage IV nZ8) or reno-
vascular hypertension (nZ4). Twelve patients wereing author. Deniz Bilecen, MD, PhD, Department of
adiology, University Hospital of Basel, Petersgraben 4,
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: dbilecen@uhbs.ch
0431 + 03 $35.00/0 q 2005 Elsevier Ltd. All rights resertreated with warfarin within the therapeutic range.
Thrombocytopenia was excluded. Transbrachial PTA
was recommended and the treated segments are listed
in Table 1.
All PTAs were carried out exclusively from the left
brachial artery. After needle puncture, the standard
transbrachial procedure included the introduction of
an overlength 0.035 in. guide wire. A 4F-pigtail
catheter was used for imaging the ascending aorta
and target vessels. Overlength 5 and 6F balloon
catheters (Biotronik, vascular intervention, Buelach,
Switzerland) were introduced for PTA. The diameters
of inflated balloons were in the range of 5–8 mm.
Endovascular peripheral interventions involved PTA
of the iliac and femoral artery, bypass-stenosis, patch-
plastic at groin level and renal artery stenosis where
transfemoral access failed. All interventions were
carried out without an introducer sheath. Warfarin-
treated patients were heparinized with 2500–5000 I.E.
heparin. After PTA, all patients received a 6F Angio-
Seale Vascular Closure Device 6F STS (St Jude
Medical, Minnetonka, Minnesota, USA). A small
compression bandage was applied and remained in
place until the following day.
The patients were monitored during the follow-
up ambulation. Evaluation was focused on local
findings including paresthesia, pain, subcutaneous
hematoma and pulse status of the radial and ulnar
artery within the next 24 h, 6 weeks and 1 year
after intervention.Eur J Vasc Endovasc Surg 31, 431–433 (2006)
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Table 1. Location of transbrachial PTA in 36 patients
Site of PTA Number
of PTAs
Common and external iliac artery stenosis/
occlusion
14
Common, superficial and deep femoral artery
stenosis
34
Bypass-anastomosis and patch-plastic at groin level 17
Renal artery stenosis 4
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The entire procedure of puncture closure with Angio-
Seale is demonstrated in more detail in Fig. 1(a)–(d).
After local skin disinfection of the antecubital fossa,
approximately 6 ml of 2% procaine is administrated in
the perivascular space. In contrast to the standard
technique of Angio-Seale deployment, 2 ml of
anesthesia are administered to increase the space
between the brachial artery and the skin (Fig. 1(a)).
Within the area of tumescence, a small skin incision
with a scalpel blade is performed and the brachial
artery is punctured by a 19-G needle. It is also
recommended to dissect carefully the tumescent area
above the vessel while the puncture needle protects
the brachial artery (Fig. 1(b)). The dissection provides
an additional subcutaneous pouch to allow theFig. 1. Recommended deployment of Angio-Seale at the brach
procaine) with subcutaneous depot to increase the space bet
anesthesia). The deposition is indicated by a formation of a hu
After arterial 19-G needle puncture, a subcutaneous pouch is c
the subcutaneous dissection, brachial artery is protected by the
device is introduced. During deployment, a collagen stripe is p
remains visible (white arrow). The prepared pouch at the beginn
the skin. (d) Skin is taped by Leukostrip to ensure the position
Eur J Vasc Endovasc Surg Vol 31, April 2006encasement of the collagen sponge at the end of
Angio-Seale deployment. This coverage is required to
ensure the position of the sponge and might facilitate
the absorption of the collagen stripe. Subsequent to
PTA, the Angio-Seale sheath is introduced in the
standard technique via a guidewire and the device is
deployed following the manufacturer’s instruction.
After pushing the tamper downwards along the
suture, the collagen sponge is compressed against
the outer vessel wall creating a collagen plug, which
remains still visible (Fig. 1(c)).
The last step includes coverage of the collagen plug
by the prepared pouch, whereby the collagen dis-
appears finally beneath the skin. This maneuver
ensures the position of the sponge and might facilitate
the absorption of the collagen stripe and might reduce
the risk of local infection. The skin incision is taped by
Leukostrip (Smith and Nephew, Largo, Florida, USA)
(Fig. 1(d)).Results
In all patients, Angio-Seale was successfully
deployed, and hemostasis was instantaneously
achieved within several minutes. The pouch enclosedial puncture site: (a) Administration of local anesthesia (2%
ween brachial artery and skin before incision (tumescence
mp. A space is created between brachial artery and skin. (b)
reated within the tumescence area by a scalpel blade. During
puncture needle itself. (c) Following PTA, the Angio-Seale
ushed towards the brachial artery, whereby a collagen plug
ing of the session is used to cover the collagen stripe beneath
of the closure of the skin at the side of incision.
Brachial Puncture Closure with Angio-Seale 433the collagen plug. The collagen knot was palpable in
all patients. No major complications occurred. In
particular, no major bleeding or pseudoaneurysm
was observed. Within the next 24 h after intervention,
minor complications included transient paresthesia
and local arm pain in three of the 36 patients (8.3%),
and small subcutaneous hematoma in six patients (16.
7%). After 1 year, none of the complications remained.
A pulse deficit of the radial and ulnar artery was never
observed in any of the patients at any time.Discussion
This is the first description of a brachial artery
puncture closure with 6F Angio-Seale. The closure
was performed in heparinized patients after transbra-
chial peripheral PTA to achieve hemostasis after 5–6F
endovascular catheterization. Because of the insuffi-
cient subcutaneous tissue of the antecubital fossa,
Angio-Seale deployment is modified compared to the
standard technique. The deployment of the Angio-
Seale closure device is described in detail. Herein, we
suggest a creation of a small pouch with tumescent
anesthesia at the beginning of the intervention. This
procedure enables the coverage of the collagen plug
beneath the skin at the end of the PTA. This step is
mandatory and commences resorption of the collagen
material.
Major complications were not observed in any of
the patients. Only minor complications including mild
paresthesia, pain and/or hematoma were reported.
Due to the limited number of patients in this retro-
spective analysis, our results are not suitable to
demonstrate precisely the rate of complications but
give rather a rough approximation of the outcome.
However, the complication rate appears to be com-
parable to that of Angio-Seale deployment for the
closure of the femoral artery.
At first glance, Angio-Seale seems to be rather
inappropriate for routine vascular closure because of
its high expense. However, this technique reduces
haemostasis time, thereby accelerated patient flow and
increasing the catheter laboratory productivity.Additionally, patients may ambulate after diagnostic
procedures after several hours.5 Furthermore, the
patient appreciates vascular closure because of the
lack of continuous compression within the antecubital
region. The tumescent technique might also be
valuable for hemostatic puncture closure of the
common femoral artery in very thin patients with
insufficient subcutaneous tissue in the groin area.
We underline that the Angio-Seale puncture
closure of the brachial artery is an off-license use.
Precaution is needed because the diameter of the
brachial artery might fall below the approved limit of
4 mm vessel diameter.Conclusion
Off-label use of Angio-Seale is feasible for puncture
closure of the brachial artery after PTA. In respect to
insufficient subcutaneous tissue of the antecubital
fossa, a modified tumescence protocol for Angio-
Seale deployment is suggested. Only minor compli-
cations occurred.References
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